upfront egfr therapy in metastatic colorectal cancer
Published 8 years ago • 112 plays • Length 7:10Download video MP4
Download video MP3
Similar videos
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
7:42
egfr-targeted therapy in metastatic colorectal cancer
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
6:04
upfront treatment of unresectable ras wild-type metastatic colorectal cancer
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
4:00
optimizing treatment with egfr inhibitors in colorectal cancer
-
5:35
emerging therapy in metastatic colorectal cancer
-
5:54
initial systemic therapy for metastatic colorectal cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
1:28
dr. mizrahi on targeting treatment in metastatic colorectal cancer
-
16:30
up-front treatment in egfr wild-type patients
-
7:59
maintenance therapy in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
13:46
choosing between vegf and egfr targeted therapy in mcrc
-
1:50
dr. benson on sequencing strategies with cetuximab in crc
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
6:01
considering maintenance therapy in metastatic colorectal cancer
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer